These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12218400)

  • 1. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy.
    Gross R; Bilker WB; Friedman HM; Coyne JC; Strom BL
    AIDS; 2002 Sep; 16(13):1835-7. PubMed ID: 12218400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How well do clinicians estimate patients' adherence to combination antiretroviral therapy?
    Miller LG; Liu H; Hays RD; Golin CE; Beck CK; Asch SM; Ma Y; Kaplan AH; Wenger NS
    J Gen Intern Med; 2002 Jan; 17(1):1-11. PubMed ID: 11903770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supporting adherence to highly active antiretroviral therapy and protected sex among people living with HIV/AIDS: the role of patient-provider communication in Rio de Janeiro, Brazil.
    Fehringer J; Bastos FI; Massard E; Maia L; Pilotto JH; Kerrigan D
    AIDS Patient Care STDS; 2006 Sep; 20(9):637-48. PubMed ID: 16987050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.
    Stone VE
    Curr HIV/AIDS Rep; 2005 Nov; 2(4):189-93. PubMed ID: 16343377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy adherence and highly active antiretroviral therapy: comparison of three sources of information.
    Vincke J; Bolton R
    AIDS Patient Care STDS; 2002 Oct; 16(10):487-95. PubMed ID: 12437860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dealing with the obstacles in adhering to highly active antiretroviral therapy.
    Hubbard M
    J Assoc Nurses AIDS Care; 2006; 17(1):18-25. PubMed ID: 16686081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness and attitude of health workers at a Nigerian HIV treatment clinic toward HIV/AIDS and HAART adherence.
    Olowookere SA; Fatiregun AA; Osagbemi KG
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):208-12. PubMed ID: 19357425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider assessment of adherence to HIV antiretroviral therapy.
    Bangsberg DR; Hecht FM; Clague H; Charlebois ED; Ciccarone D; Chesney M; Moss A
    J Acquir Immune Defic Syndr; 2001 Apr; 26(5):435-42. PubMed ID: 11391162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
    Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
    Ann Intern Med; 2003 Nov; 139(10):810-6. PubMed ID: 14623618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.
    Tegegne AS; Ndlovu P; Zewotir T
    BMC Infect Dis; 2018 Feb; 18(1):83. PubMed ID: 29458343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients.
    Wong MD; Cunningham WE; Shapiro MF; Andersen RM; Cleary PD; Duan N; Liu HH; Wilson IB; Landon BE; Wenger NS;
    J Gen Intern Med; 2004 Apr; 19(4):366-74. PubMed ID: 15061746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.
    Murri R; Ammassari A; Trotta MP; De Luca A; Melzi S; Minardi C; Zaccarelli M; Rellecati P; Santopadre P; Soscia F; Scasso A; Tozzi V; Ciardi M; Orofino GC; Noto P; Monforte Ad; Antinori A; Wu AW;
    J Gen Intern Med; 2004 Nov; 19(11):1104-10. PubMed ID: 15566439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to HAART regimens.
    Chesney M
    AIDS Patient Care STDS; 2003 Apr; 17(4):169-77. PubMed ID: 12737640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to antiretroviral adherence among HIV-infected adults.
    Murphy DA; Roberts KJ; Martin DJ; Marelich W; Hoffman D
    AIDS Patient Care STDS; 2000 Jan; 14(1):47-58. PubMed ID: 12240882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S
    Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.